Atypical post-finasteride syndrome: A pharmacological riddle

Finasteride and dutasteride are commonly used 5-alpha reductase inhibitors. While finasteride is a selective inhibitor of 5-alpha reductase Type II, dutasteride inhibits 5- alpha reductase Type I and II. The United States Food and Drug Administration approved the use of finasteride for benign prosta...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Anita K., Sharma, Neetu, Shukla, Prashant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Drug Watch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900007/
https://www.ncbi.nlm.nih.gov/pubmed/27298504
http://dx.doi.org/10.4103/0253-7613.182898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900007/
https://www.ncbi.nlm.nih.gov/pubmed/27298504
http://dx.doi.org/10.4103/0253-7613.182898

Ejemplares similares